Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Managed Care Pharmacy : JMCP|February 6, 2007
The role of outcomes research in defining and measuring value in benefit decisionsMichael B Nichol
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Depression and health-related quality of life in patients with rheumatoid arthritisMichael B Nichol, Lihua Zhang
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 11, 2008
Separating gains and losses in health when calculating the minimum important difference for mapped utility measuresMichael B Nichol, Joshua D Epstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistaminesPatrick W Sullivan, Michael B Nichol
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 2, 2006
Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular riskPatrick Thiebaud, Bimal V Patel, Michael B Nichol
Health Economics|June 23, 2007
The demand for statin: the effect of copay on utilization and compliancePatrick Thiebaud, Bimal V Patel, Michael B Nichol
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2010
Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes--an application of marginal structural modelsAndrew P Yu, Yanni F Yu, Michael B Nichol
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed RatesChristina X Chen, Judith R Baker, Michael B Nichol
Medical Care|December 12, 2003
Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysisPatrick W Sullivan, Sheryl L Follin, Michael B Nichol
Pageof 7